Position in GRAL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,259,875
+$11,262,032 QoQ
Shares Held
194,227
+402.4% QoQ
Ownership
0.435%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 374 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $2,228,724,937 across 35 Diagnostics & Research names. GRAL ranks #16 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,458,431 | $731,198,964 | |
| 2 | DHR |
Danaher Corp /De/
|
2,107,482 | $401,433,168 | |
| 3 | DGX |
Quest Diagnostics Inc
|
1,751,220 | $371,171,075 | |
| 4 | NTRA |
Natera, Inc.
|
502,818 | $136,489,944 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
209,092 | $110,074,391 | |
| 6 | LH |
Labcorp Holdings Inc.
|
347,544 | $97,312,320 | |
| 7 | WAT |
Waters Corp /De/
|
168,498 | $63,193,487 | |
| 8 | A |
Agilent Technologies, Inc.
|
462,412 | $61,422,185 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,259,875 | 194,227 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,997,843 | 38,658 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,592,106 | 65,336 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,204,962 | 54,202 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,504,341 | 29,256 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $124,684 | 4,882 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $90,390 | 5,064 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $93,263 | 6,778 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $346,760 | 22,561 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||